DVA|Analyst Targets
DVA|Company Info
DVA|Insider Trading
DVA|Fundamentals
DVA|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.57 | - | - |
| Q2'26 | $3.92 | $4.02 | +2.5% |
| Q1'26 | $2.33 | $2.87 | +23.2% |
| Q3'25 | $3.17 | $2.51 | -20.9% |
| Q2'25 | $2.75 | $2.95 | +7.3% |
| Q1'25 | $2.02 | $2.00 | -1.0% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.5B | - | - |
| Q2'26 | $3.5B | $3.6B | +0.6% |
| Q1'26 | $3.4B | $3.4B | +1.8% |
| Q3'25 | - | $3.4B | - |
| Q2'25 | - | $3.4B | - |
| Q1'25 | - | $3.2B | - |
DVA|Monthly Returns
Market Data
DVA Stock Snapshot
- Market cap
- 11.60B
- P/E ratio
- 13.7
- Day range
- $181.69 – $183.70
- News sentiment
- 70/100 · Bullish
- Analyst target
- $219.86 (+20.7%)
- Consensus
- Buy · 14 analysts
DaVita Inc. is consolidating: price is in the middle of its 52-week range without a decisive push either way. Sector peers are worth watching - large caps in Healthcare tend to move together on rotation.
Reverse DCF
What growth is priced into DVA?
At today's price, DaVita Inc. needs to grow free cash flow about -8.5% a year for the next 10 years to justify its valuation at a 6.20% cost of capital. Over its actual history it has compounded free cash flow at 8.2% a year, so the market is asking for 16.7 percentage points below its own delivered rate. On that basis DVA looks priced below what its own growth record supports.
- Implied FCF growth
- -8.5%
- Historical FCF CAGR
- 8.2%
- Growth gap
- -16.7 pts
- Verdict
- CHEAP
- Discount rate (WACC)
- 6.20%
- Beta
- 0.55
Behaviour On Record
What DVA's own history says about today's numbers
- Realized volatility (21d)
- 32.9% 74th pct
- Below its peak
- -25.6%
- vs 200-day average
- +4.7%
- Up days (1y)
- 53%
DaVita Inc. is currently running 32.9% annualised volatility over the last 21 sessions. Measured against DVA's own 13 years of daily returns rather than a market-wide average, that is the 74th percentile — a little above its own norm, against a typical reading of 24.6%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
DVA is trading -25.6% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -27.8%, and the deepest was -46.7% in 2022. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +4.7% from its 200-day moving average. Against every other day in its history, that gap ranks at the 54th percentile — close to the gap it normally carries. Over the past year DVA closed higher on 53% of sessions, and it is currently 3 sessions into a rising streak.
On October specifically: over 13 years of records, DVA finished the month higher 5 of 13 times, with a median return of -8.5% and an average of -5.2%. Its strongest month historically has been November at +7.0% on average, its weakest October at -5.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: DVA has opened more than 2% away from the prior close in 93 of 3,266 sessions (2.8% of the time), with the largest gaps running +8.3% and -7.4%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,267 daily closes between 2013-10-14 and 2026-10-09, split-adjusted, recomputed daily. Percentiles are against DVA's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of DVA's sector?
DaVita Inc. sits in the Health Care sector, currently ranked 4th of 12 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #4 of 12
- Sector state
- Improving
- Sector rotation score
- 73
Analyst Rating Changes
Are analysts turning bullish or bearish on DVA?
TD Cowen most recently upgraded DaVita Inc. to Buy on Aug 7, 2026 with a price target of $220 (from $201). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.
- Latest action
- TD Cowen — Buy
- 90-day upgrades
- 1
- 90-day downgrades
- 0
- Net rating momentum
- +1
Peers & ETF holders
DVA peers & ETF holders
Medical Care FacilitiesMarket cap · today
- DVAYou're here$11.6B+0.01%
- HCAHCA Healthcare, Inc.$99.0B-0.38%
- UHSUniversal Health Services, Inc.$10.5B-0.05%
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Berkshire Hathaway Inc | ▼ Sell | 28,880,209 | 45.31% | $6.43B | 2026-08-14 |
| BlackRock, Inc. | ▼ Sell | 2,460,987 | 3.86% | $547.52M | 2026-08-07 |
| Vanguard Group Inc | ▼ Sell | 4,154,354 | 6.52% | $471.98M | 2026-01-29 |
| Morgan Stanley | ▼ Sell | 1,601,710 | 2.51% | $356.35M | 2026-08-13 |
| Invesco Ltd. | ▼ Sell | 1,211,917 | 1.90% | $269.63M | 2026-08-14 |
| Neuberger Berman Group LLC | ▲ Buy | 925,579 | 1.45% | $205.76M | 2026-08-13 |
| Geode Capital Management, LLC | ▼ Sell | 853,602 | 1.34% | $189.56M | 2026-08-12 |
| Bank of America Corp | ▲ Buy | 651,999 | 1.02% | $145.06M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 640,827 | 1.01% | $142.57M | 2026-08-14 |
| AQR Capital Management LLC | ▲ Buy | 587,758 | 0.92% | $128.13M | 2026-08-14 |
| Goldman Sachs Group Inc | ▲ Buy | 463,381 | 0.73% | $103.09M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 382,037 | 0.60% | $85.00M | 2026-08-13 |
| Norges Bank | ▼ Sell | 344,422 | 0.54% | $76.63M | 2026-08-12 |
| JPMorgan Chase & Co | ▼ Sell | 200,781 | 0.32% | $44.47M | 2026-08-12 |
| Citadel Advisors LLC | ▼ Sell | 199,862 | 0.31% | $44.47M | 2026-09-02 |
| Gotham Asset Management, LLC | ▼ Sell | 163,580 | 0.26% | $36.39M | 2026-08-14 |
| FMR LLC (Fidelity) | ▲ Buy | 114,507 | 0.18% | $25.48M | 2026-08-13 |
| Davidson Kempner Capital Management LP | ▲ Buy | 113,098 | 0.18% | $25.16M | 2026-08-14 |
| Millennium Management LLC | ▲ Buy | 77,094 | 0.12% | $17.15M | 2026-08-14 |
| Verition Fund Management LLC | ▲ Buy | 43,780 | 0.07% | $9.74M | 2026-08-14 |
| Brevan Howard Capital Management LP | ▲ Buy | 37,500 | 0.06% | $8.34M | 2026-08-14 |
| Marshall Wace, LLP | ▲ Buy | 36,897 | 0.06% | $8.21M | 2026-08-13 |
| Wells Fargo & Company | ▲ Buy | 29,486 | 0.05% | $6.56M | 2026-08-14 |
| Susquehanna International Group, LLP | ▼ Sell | 28,799 | 0.05% | $6.41M | 2026-08-14 |
| Citigroup Inc | ▼ Sell | 28,610 | 0.04% | $6.37M | 2026-08-03 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Julie Johnson | House | TX32 | ▼ Sell | $1K - $15K | 2025-09-25 | 2025-10-07 |
| Julie Johnson | House | TX32 | ▲ Buy | $1K - $15K | 2025-09-23 | 2026-08-05 |
| Julie Johnson | House | TX32 | ▼ Sell | $1K - $15K | 2025-09-23 | 2026-08-05 |
| Jerry Moran | Senate | - | ▼ Sell | $1K - $15K | 2023-12-14 | 2024-01-17 |
| Tommy Tuberville | Senate | AL | ▼ Sell | $1K - $15K | 2023-12-12 | 2024-01-12 |
| Tommy Tuberville | Senate | AL | ▼ Sell | $1K - $15K | 2023-06-12 | 2023-07-14 |
| Jerry Moran | Senate | - | ▼ Sell | $1K - $15K | 2021-12-21 | 2022-01-21 |
| Jerry Moran | Senate | - | ▲ Buy | $1K - $15K | 2018-12-06 | 2019-05-15 |